MDM2 and mitochondrial function: One complex intersection

被引：13

作者：

Rubio-Patino, Camila ^{[1
,2
]}

Trotta, Andrew Paul ^{[1
,2
]}

Chipuk, Jerry Edward ^{[1
,2
,3
,4
,5
,6
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

[3] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

[4] Icahn Sch Med Mt Sinai, Dept Dermatol, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Dermatol, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

[6] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, One Gustave L Levy Pl,Box 1130, New York, NY 10029 USA

来源：

BIOCHEMICAL PHARMACOLOGY | 2019年 / 162卷

关键词：

Apoptosis; Bioenergetics; Complex I; Electron transport chain; MDM2; Mitochondria; Oncogene; p53; Tumor suppressor; DEPENDENT PROTEIN-KINASE; DNA-ENCODED SUBUNITS; P53; PROTEIN; OXIDATIVE-PHOSPHORYLATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; ELECTRON-TRANSPORT; GENE AMPLIFICATION; OVEREXPRESSION; CANCER;

D O I：

10.1016/j.bcp.2018.10.032

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Decades of research reveal that MDM2 participates in cellular processes ranging from macro-molecular metabolism to cancer signaling mechanisms. Two recent studies uncovered a new role for MDM2 in mitochondrial bioenergetics. Through the negative regulation of NDUFS1 (NADH:ubiquinone oxidoreductase 75 kDa Fe-S protein 1) and MT-ND6 (NADH dehydrogenase 6), MDM2 decreases the function and efficiency of Complex I (CI). These observations propose several important questions: (1) Where does MDM2 affect CI activity? (2) What are the cellular consequences of MDM2-mediated regulation of CI? (3) What are the physiological implications of these interactions? Here, we will address these questions and position these observations within the MDM2 literature.

引用

页码：14 / 20

页数：7

共 50 条

[31] MDM2 variant in tumorigenesis
Vogan, K
NATURE GENETICS, 2005, 37 (01) : 17 - 17
[32] Mdm2: The Ups and Downs
Tamar Juven-Gershon
Moshe Oren
Molecular Medicine, 1999, 5 : 71 - 83
[33] Posttransiational modification of MDM2
Meek, DW
Knippschild, U
MOLECULAR CANCER RESEARCH, 2003, 1 (14) : 1017 - 1026
[34] Conditional inactivation of Mdm2
Mary Ellen Perry
Susan Mendrysa
Nature Genetics, 2001, 27 (Suppl 4) : 78 - 79
[35] MDM2 in breast cancer
Masakazu Toi
Shigehira Saji
Akio Suzuki
Yutaka Yamamoto
Takeshi Tominaga
Breast Cancer, 1997, 4 (4) : 264 - 268
[36] Mdm2 as a chromatin modifier
Wienken, Magdalena
Moll, Ute M.
Dobbelstein, Matthias
JOURNAL OF MOLECULAR CELL BIOLOGY, 2017, 9 (01) : 74 - 80
[37] The molecular dynamics of MDM2
Nicholson, Judith
Hupp, Ted R.
CELL CYCLE, 2010, 9 (10) : 1878 - 1881
[38] Functions of the MDM2 oncoprotein
D. A. Freedman
L. Wu
A. J. Levine
Cellular and Molecular Life Sciences CMLS, 1999, 55 : 96 - 107
[39] Mdm2: Open questions
Dobbelstein, Matthias
Levine, Arnold J.
CANCER SCIENCE, 2020, 111 (07) : 2203 - 2211
[40] Functions of the MDM2 oncoprotein
Freedman, DA
Wu, L
Levine, AJ
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) : 96 - 107

← 1 2 3 4 5 →